Northwestern Ovarian Cancer Early Detection and Prevention Program (NOCEDPP)
Overview
The Northwestern Ovarian Cancer Early Detection and Prevention Program (NOCEDPP), under the direction of Lee Shulman, MD and Diljeet Singh, MD, is a collaborative effort between National Cancer Institute Northwestern University and the Robert H. Lurie Comprehensive Cancer Center of Northwestern. The NOCEDPP is both a clinical and a research program.
What is the purpose of the NOCEDP?
The clinical program combines the expertise of gynecologic oncology, genetics, ultrasonography, biochemistry and molecular biology to offer a comprehensive detection program for women at risk for developing ovarian cancer and for women diagnosed with the disease. The NOCEDPP research program is directed at developing tests to detect ovarian cancer earlier, identifying prevention and therapy approaches, and improving the quality of life for women at risk for developing ovarian cancer and for those who have already been diagnosed.
The NOCEDPP provides focused, high-quality innovative care and services for asymptomatic women at increased risk of developing ovarian cancer. The hallmark of the program is the coordinated, multidisciplinary services provided during each comprehensive clinic visit.
The NOCEDPP, along with the sections of Gynecologic Oncology, Hematology/Oncology and Surgical Oncology, have joined forces with the Robert H. Lurie Comprehensive Cancer Center. The Cancer Center provides a full range of oncology services and provides access to specialized research, clinical trials and diagnostic services.
Who Care is Provided For
Our physicians provide care for many medical conditions including (but not limited to) the following:
- Women who have a personal or family history of a hereditary cancer syndrome that includes an increased risk of gynecologic cancer, including BRCA1 and BRCA2 genetic mutation or Lynch syndrome (HNPCC)
- Women who have one or more a first degree relatives (mother, sister, aunt) with ovarian, primary peritoneal, or fallopian tube cancer
- Women with a personal history of breast or colon cancer
- Women who have two or more family members with either breast, ovarian, primary peritoneal, fallopian tube, colon, uterine, and/or pancreatic cancer
- Women who have a diagnosis of a reproductive cancer or a highly suspicious adnexal mass
Treatments and procedures
Our physicians offer a comprehensive array of diagnostic and therapeutic procedures and consultations including:
- Genetic counseling and risk assessment
- Clinical breast, pelvic, and rectal exam
- Transvaginal ultrasound
- CA-125 blood test
Contact Numbers
Practice Phone Number: (312) 926-6606
Fax: (312) 926-2889
Practice Information
Doctors
Department Chair(s): Sherman Elias, MD
Ambulatory Medical Director(s): Lee Shulman, MD and Diljeet Singh, MD, DrPH
Division Chief(s): Julian C. Schink, MD
Physicians in the Practice
Jeffrey S. Dungan, MD
Lee P. Shulman, MD
Diljeet K. Singh, MD, DrPH
Office Location
Northwestern Medical Faculty Foundation
Galter Pavilion
675 North St Clair
14-200
Chicago, Illinois 60611
Office Hours
Monday: closed
Tuesday: closed
Wednesday: 8:00-4:30
Thursday: 8:00-4:30
Friday: closed
Saturday: closed
Sunday: closed
